Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Vaccines |
Free Subscription
2 BMJ |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Vaccines is free of charge.
RSV vaccines administered in error to infants and pregnant people, CDC reports.
BMJ. 2024;384:q236.
PubMed
Measles outbreaks: Investing in patient relationships through GP continuity will
be key to boosting MMR confidence.
BMJ. 2024;384:q221.
PubMed
Layering vaccination with antibiotic therapy results in protection and clearance
of Burkholderia pseudomallei in Balb/c mice.
Infect Immun. 2024 Jan 30:e0045523. doi: 10.1128/iai.00455.
PubMed
Abstract available
Less is more: uptake of recommended vaccines in a UK Travel Clinic.
J Infect. 2024 Jan 25:S0163-4453(24)00027-6. doi: 10.1016/j.jinf.2024.
PubMed
Safety, Tolerability and Immunogenicity of a mRNA-based RSV Vaccine in Healthy
Young Adults in a Phase 1 Clinical Trial.
J Infect Dis. 2024 Jan 31:jiae035. doi: 10.1093.
PubMed
Abstract available
IL-17 and IFN-gamma-producing respiratory tissue resident memory CD4 T cells persist
for decades in adults immunized as children with whole cell pertussis vaccines.
J Infect Dis. 2024 Jan 30:jiae034. doi: 10.1093.
PubMed
Abstract available
Hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant
antibody responses compared to natural infection or vaccination alone.
J Infect Dis. 2024 Jan 29:jiae046. doi: 10.1093.
PubMed
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5
variant in Syrian hamsters.
J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
PubMed
Abstract available
Translational success of fundamental virology: a VSV-vectored Ebola vaccine.
J Virol. 2024 Feb 2:e0162723. doi: 10.1128/jvi.01627.
PubMed
Abstract available
Enhanced antigen-specific CD8 T cells contribute to early protection against FMDV
through swine DC vaccination.
J Virol. 2024 Jan 30:e0200223. doi: 10.1128/jvi.02002.
PubMed
Abstract available
Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.
PubMed
Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3,
randomised controlled trial in Malawian children.
Lancet. 2024 Jan 25:S0140-6736(23)02031-7. doi: 10.1016/S0140-6736(23)02031.
PubMed
Abstract available
Long-term protection conferred by typhoid conjugate vaccines: a step towards
typhoid elimination?
Lancet. 2024 Jan 25:S0140-6736(23)02350-4. doi: 10.1016/S0140-6736(23)02350.
PubMed
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine
Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to
Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing
Community Access to Testing Pro
MMWR Morb Mortal Wkly Rep. 2024;73:77-83.
PubMed
Abstract available
Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans
Health Administration, March-September 2022.
MMWR Morb Mortal Wkly Rep. 2024;73:57-61.
PubMed
Abstract available
Three Dengue Vaccines - What Now?
N Engl J Med. 2024;390:464-465.
PubMed
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.
N Engl J Med. 2024;390:397-408.
PubMed
Abstract available
Modeling geographic vaccination strategies for COVID-19 in Norway.
PLoS Comput Biol. 2024;20:e1011426.
PubMed
Abstract available
A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and
disease incidence in German healthcare workers before and during the rollout of
COVID-19 vaccines.
PLoS One. 2024;19:e0294025.
PubMed
Abstract available
Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions
and behavior among international and domestic college students in the United
States.
PLoS One. 2024;19:e0293130.
PubMed
Abstract available
Modelling the health and economic impacts ofM72/AS01(E) vaccination and
BCG-revaccination: Estimates for South Africa.
Vaccine. 2024 Feb 1:S0264-410X(24)00096-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Utilizing a university testing program to estimate relative effectiveness of
monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against
symptomatic SARS-CoV-2 infection.
Vaccine. 2024 Feb 1:S0264-410X(24)00103-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Safety of incidental exposure to the novel oral poliovirus vaccine type 2 in
pregnancy: A longitudinal observational study in Mozambique, 2022-2023.
Vaccine. 2024 Feb 1:S0264-410X(24)00095-1. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the
phase 3b implementation Sisonke study in South Africa.
Vaccine. 2024 Jan 25:S0264-410X(24)00078-1. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Systematic review of cost projections of new vaccine introduction.
Vaccine. 2024 Jan 25:S0264-410X(24)00024-0. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
The U.S. COVID-19 vaccination program: A look back and future directions.
Vaccine. 2024 Jan 26:S0264-410X(24)00065-3. doi: 10.1016/j.vaccine.2024.
PubMed
Are COVID-19 vaccination mandates for healthcare workers effective? A systematic
review of the impact of mandates on increasing vaccination, alleviating staff
shortages and decreasing staff illness.
Vaccine. 2024 Jan 27:S0264-410X(24)00052-5. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Association between regular physical activity and pneumonia-related
hospitalization according to pneumococcal vaccination status: The VENUS study.
Vaccine. 2024 Jan 27:S0264-410X(24)00072-0. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Efficacy of novel staphylococcal surface associated protein vaccines against
Staphylococcus aureus and non-aureus staphylococcal mastitis in dairy cows.
Vaccine. 2024 Jan 27:S0264-410X(24)00079-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Impact of the 'Health on Wheels' (HoW) strategy on COVID-19 vaccination coverage
in hard-to-reach communities in Alta Verapaz, Guatemala, 2022.
Vaccine. 2024 Jan 27:S0264-410X(24)00033-1. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children
aged 5-11 years, a nationwide parental survey.
Vaccine. 2024 Jan 27:S0264-410X(24)00067-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Effectiveness of 13-valent pneumococcal conjugate vaccine against
vaccine-serotype community acquired pneumococcal diseases among children in
China: A test-negative case-control study.
Vaccine. 2024 Jan 30:S0264-410X(24)00080-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Flu-COVID combo recombinant protein vaccines elicited protective immune responses
against both influenza and SARS-CoV-2 viruses infection.
Vaccine. 2024 Jan 30:S0264-410X(23)01543-8. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Erratum to "Examining vaccine hesitancy among a diverse sample of Canadian
adults" [Vaccine 42(2) (2024) 129-135].
Vaccine. 2024 Jan 30:S0264-410X(24)00061-6. doi: 10.1016/j.vaccine.2024.
PubMed
Cryptic vaccine-associated adverse events: The critical need for a new vaccine
safety surveillance paradigm to improve public trust in vaccines.
Vaccine. 2024 Jan 30:S0264-410X(24)00070-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
AI and the future of vaccine development.
Vaccine. 2024 Jan 30:S0264-410X(24)00071-9. doi: 10.1016/j.vaccine.2024.
PubMed
Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type
SARS-CoV-2 and Omicron variants in a murine model.
Vaccine. 2024 Jan 30:S0264-410X(24)00097-5. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine
formulated with a functional polymer.
Vaccine. 2024 Jan 31:S0264-410X(24)00077-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Costs of human papillomavirus vaccine delivery in low- and middle-income
countries: A systematic review.
Vaccine. 2024 Jan 31:S0264-410X(24)00118-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune
thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions
and guidelines for data collection, analysis, and presentation of immunisation
safety data.
Vaccine. 2024 Jan 31:S0264-410X(24)00057-4. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Longitudinal parental perception of COVID-19 vaccines for children in a
multi-site, cohort study.
Vaccine. 2024 Feb 2:S0264-410X(24)00010-0. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study.
Vaccine. 2024 Feb 1:S0264-410X(24)00128-2. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Evidence that an interaction between the respiratory syncytial virus F and G
proteins at the distal ends of virus filaments mediates efficient multiple cycle
infection.
Virology. 2024;591:109985.
PubMed
Abstract available
Thank you for your interest in scientific medicine.